Adolescents Should Get A Vaccine Against Bacterial Meningitis – Part 2 of 3
Some at the meeting wondered if it was even necessary to make such a decision. Cases of bacterial meningitis are at historic lows, and a assess of more than 200 colleges and universities – representing more than 2 million students – in the last academic year found 11 cases of bacterial meningitis and three deaths, the AP reported.
In a scuttlebutt release issued after the vote, the National Meningitis Association said it “supports the decision to maintain meningococcal immunization at age 11-12 and to add a booster dose to provide increased blocking of disease among adolescents throughout their high-risk years. This is a good public health decision that will protect our children from meningococcal disease”.
Meningitis is an inflammation of the membranes that cover the brain and spinal cord, and is most often caused by a viral or bacterial infection. The disease can result in brain damage, hearing loss or learning disabilities, according to the CDC. In January, the New England Journal of Medicine published a exploration that found that rates of pneumococcal meningitis have declined substantially since a vaccine was introduced in 2000.